Breaking News Instant updates and real-time market news.

GMAB

Genmab

$22.73 /

-0.13 (-0.57%)

, JNJ

Johnson & Johnson

$149.07 /

+0.82 (+0.55%)

16:25
01/20/20
01/20
16:25
01/20/20
16:25

Genmab announces European Marketing Authorization for DARZALEX

Genmab A/S (GMAB) announced that the European Commission has granted marketing authorization for DARZALEX in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant. The EC approval follows a positive opinion issued for DARZALEX by the CHMP of the European Medicines Agency in December 2019. In August 2012, Genmab granted Janssen Biotech (JNJ) an exclusive worldwide license to develop, manufacture and commercialize daratumumab. The approval was based on the Phase III CASSIOPEIA study.

GMAB

Genmab

$22.73 /

-0.13 (-0.57%)

JNJ

Johnson & Johnson

$149.07 /

+0.82 (+0.55%)

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

GMAB Genmab
$22.73 /

-0.13 (-0.57%)

01/13/20 SunTrust
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
JNJ Johnson & Johnson
$149.07 /

+0.82 (+0.55%)

01/10/20 BWS Financial
Anika acquisitions set up direct competition with partner, says BWS Financial
01/09/20 JMP Securities
Argenx price target raised to $170 from $164 at JMP Securities
01/09/20 Wells Fargo
Johnson & Johnson price target raised to $165 from $155 at Wells Fargo
12/30/19 H.C. Wainwright
J&J declining option with Provention for PRV-6527 expected, says H.C. Wainwright

TODAY'S FREE FLY STORIES

Earnings
Insmed reports Q4 GAAP EPS (59c), consensus (58c) » 07:34
02/25/20
02/25
07:34
02/25/20
07:34
INSM

Insmed

$29.84 /

-1.39 (-4.45%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Golar LNG Partners says Q1 to be negatively impacted by Golar Igloo downtime » 07:33
02/25/20
02/25
07:33
02/25/20
07:33
GMLP

Golar LNG Partners

$4.34 /

-0.29 (-6.26%)

The 4Q award of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lindblad Expeditions sees FY20 tour revenue $400M-$410M, consensus $392.93M » 07:32
02/25/20
02/25
07:32
02/25/20
07:32
LIND

Lindblad Expeditions

$13.79 /

-1.1 (-7.39%)

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Golar LNG Partners reports Q4 operating revenue $76.5M, consensus $79.35M  07:32
02/25/20
02/25
07:32
02/25/20
07:32
GMLP

Golar LNG Partners

$4.34 /

-0.29 (-6.26%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lindblad Expeditions reports Q4 EPS (3c), consensus (4c) » 07:31
02/25/20
02/25
07:31
02/25/20
07:31
LIND

Lindblad Expeditions

$13.79 /

-1.1 (-7.39%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
JPMorgan starts Reynolds Consumer at Overweight, adds to Analyst Focus List » 07:31
02/25/20
02/25
07:31
02/25/20
07:31
REYN

Reynolds Consumer Products

$30.13 /

-0.56 (-1.82%)

JPMorgan analyst Andrea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
1Life Healthcare initiated with an Overweight at JPMorgan » 07:29
02/25/20
02/25
07:29
02/25/20
07:29
ONEM

1Life Healthcare

$22.32 /

-1.6 (-6.69%)

JPMorgan analyst Lisa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Golar LNG reports Q4 operating revenue $139M, consensus $135.54M » 07:29
02/25/20
02/25
07:29
02/25/20
07:29
GLNG

Golar LNG

$11.05 /

-1.02 (-8.45%)

Iain Ross, CEO, Golar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Shake Shack price target lowered to $76 from $83 at Credit Suisse » 07:28
02/25/20
02/25
07:28
02/25/20
07:28
SHAK

Shake Shack

$73.57 /

-1.215 (-1.62%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Realogy says plans to prioritize investing in its business, reducing leverage » 07:27
02/25/20
02/25
07:27
02/25/20
07:27
RLGY

Realogy

$12.88 /

-0.23 (-1.75%)

The company expects to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Intercept sees 2020 non-GAAP operating expenses $560M-$600M » 07:26
02/25/20
02/25
07:26
02/25/20
07:26
ICPT

Intercept

$90.77 /

-4.24 (-4.46%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Realogy reports Q4 adjusted EPS 20c, consensus 9c » 07:26
02/25/20
02/25
07:26
02/25/20
07:26
RLGY

Realogy

$12.88 /

-0.23 (-1.75%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
QTS Realty Trust price target raised to $64 from $52 at Credit Suisse » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
QTS

QTS Realty Trust

$60.88 /

-2.12 (-3.37%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Aurora Cannabis initiated with a Hold at Needham » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
ACB

Aurora Cannabis

$1.56 /

-0.11 (-6.59%)

Needham analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
BofA says survey shows Atlassian's opportunities larger than thought » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
TEAM

Atlassian

$147.20 /

+1.18 (+0.81%)

BofA analyst Nikolay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
IMV Inc. to host conference call » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
IMV

IMV Inc.

$4.77 /

+ (+0.00%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Freshpet to host investor day » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
FRPT

Freshpet

$73.68 /

-0.46 (-0.62%)

Investor day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
JPMorgan to host investor day » 07:25
02/25/20
02/25
07:25
02/25/20
07:25
JPM

JPMorgan

$132.16 /

-3.65 (-2.69%)

Investor day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Intercept reports Q4 EPS ($2.99), consensus ($2.67 » 07:24
02/25/20
02/25
07:24
02/25/20
07:24
ICPT

Intercept

$90.77 /

-4.24 (-4.46%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Healthpeak management to meet with RBC Capital » 07:24
02/25/20
02/25
07:24
02/25/20
07:24
PEAK

Healthpeak

$37.12 /

-0.035 (-0.09%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Realogy renames operating segments » 07:23
02/25/20
02/25
07:23
02/25/20
07:23
RLGY

Realogy

$12.88 /

-0.23 (-1.75%)

, BID

Sotheby's

$0.00 /

+ (+0.00%)

Realogy announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
HP Inc. upgraded to Buy from Hold at Loop Capital » 07:23
02/25/20
02/25
07:23
02/25/20
07:23
HPQ

HP Inc.

$22.13 /

-0.55 (-2.43%)

, XRX

Xerox

$34.90 /

-1.45 (-3.99%)

Loop Capital analyst…

Loop Capital analyst Ananda Baruah upgraded HP Inc. (HPQ) to Buy from Hold with a price target of $28, up from $19. The stock closed Monday down 60c to $22.10. The company's earnings call included a handful of announcements that suggest the stock "continues to move higher from here through various means," Baruah tells investors in a research note. These include HP's new buyback as well as an incremental cost saves plan that places 2022 earnings per share at $3.25, says the analyst. Further, Baruah notes that HP stated it would be contacting Xerox (XRX) to see if a deal could be reached that appropriately rewards its shareholders.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Evolus reports Q4 EPS (47c), consensus (73c) » 07:22
02/25/20
02/25
07:22
02/25/20
07:22
EOLS

Evolus

$9.35 /

-0.89 (-8.69%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Home Depot outlook affirmed with upside bias seen, says Baird » 07:21
02/25/20
02/25
07:21
02/25/20
07:21
HD

Home Depot

$239.77 /

-5.56 (-2.27%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Palo Alto Networks price target lowered to $240 from $275 at Wedbush » 07:21
02/25/20
02/25
07:21
02/25/20
07:21
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.